Digital PCR (dPCR) & real time PCR (qPCR) market is estimated to be over US$ 4.0 billion in 2019. It is anticipated to grow at a CAGR of 8.3% from 2019 to 2030.
Rising incidences of infectious diseases as well as in genetic disorders is anticipated to boost the dPCR & qPCR market during the forecast period. Moreover, advancements in dPCR techniques are promising as they are able to detect certain rare types of cancers. Thus, their use in diagnostics is increasing, further developing the interest of researchers. However, high cost for dPCR & qPCR equipment and technical limitations are hindering market growth to a certain extent.
Major Key Players of the Digital PCR (dPCR) & Real time PCR (qPCR) Market are:
Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN, Merck KGaA, F. Hofman-La Roche Ltd., Danaher, Takara Bio Inc., BD (Becton, Dickinson and Company), Meridian Life Science, Inc., Agilent Technologies, Inc. and others.
No comments:
Post a Comment